Coreline Soft is a pioneering healthcare startup that focuses on AI-based imaging diagnosis packages, with a specialization in lung-related conditions. The company's offerings include lung cancer screening (LCS), COPD quantification, and coronary artery calcification (CAC) systems, collectively referred to as B3 systems, which cover the three major diseases in thoracic imaging. Notably, Coreline Soft is the Official solution provider for the nationwide lung cancer screening program in Korea (K- LUCAS), serving as the 2nd state-level-reimbursed LCS program after the US. Additionally, the company has secured a significant role as the Official solution provider of 4-ITLR project by the Nelson Team (Erasmus MC and iDNA in the Netherlands), a large early detection LCS Trial based on the B3 system. Furthermore, Coreline Soft is set to become the Official solution provider for the German Trial by multi-university hospitals, signifying a pilot project to demonstrate the national support necessary for LCS in Germany. The company's COPD systems have garnered recognition from European customers, including NZ Leuven Belgium, Leicester Univ UK, and Parma Univ Italy, as the best-in-class for early detection, phenotyping, surgery support, and more. With its establishment in 2012 in South Korea, Coreline Soft represents a significant player in the healthcare technology landscape.
No recent news or press coverage available for Coreline Soft.